Actively Recruiting

Age: 18Years - 80Years
All Genders
NCT06454396

Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

Led by RenJi Hospital · Updated on 2024-06-12

480

Participants Needed

1

Research Sites

208 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This study was aimed at evaluating the efficacy of different endovascular treatments for early and mid-stage clinical interventions in patients with autologous arteriovenous fistulae loss of function and the corresponding health economic value.

CONDITIONS

Official Title

Effectiveness and Health Economics of Endoluminal Treatment of Autologous Arteriovenous Endovascular Fistula Failure

Who Can Participate

Age: 18Years - 80Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Hemodialysis patients aged over 18 and under 80 years
  • Patients with autologous arteriovenous fistula unable to be used for hemodialysis
  • Guidewire must have passed through at least the stenosis of the endovascular fistula near the lesion before enrollment
  • Patients who failed initial target lesion opening but succeeded on a second endoluminal therapy attempt
  • Patients and their legal representatives must understand the study, consent voluntarily, and agree to scheduled follow-ups
Not Eligible

You will not qualify if you...

  • Planned kidney transplant or switch to peritoneal dialysis
  • Women who are pregnant, breastfeeding, or planning pregnancy during the study
  • Recent (within 30 days) or planned surgical procedure for hemodialysis access
  • Allergy or contraindication to heparin, contrast media, or antiplatelet drugs
  • Participation in interfering clinical trials within the last 3 months
  • History of coagulation or other hematological disorders
  • Conditions reducing life expectancy significantly (less than 2 years), such as tumors, severe liver disease, or cardiac insufficiency
  • Life expectancy less than 6 months
  • Unable or unwilling to participate in the trial

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Renji Hospital

Shanghai, Shanghai Municipality, China

Actively Recruiting

Loading map...

Research Team

J

Jingpu Zhu

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here